Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors

Product is added to your Wishlist

Global IVF Market: Focus on Procedures, Instruments, and Reagents & Media - Analysis & Forecast, 2016-2022

The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. The global market is expected to grow over $26.08 billion by 2022. IVF Market can be further divided into various segments and sub-segments.

SKU: BH009A
Published Year: 2016
 
 

In recent times, there has been a huge increase in the demand for the Assisted Reproductive Techniques (ART). Infertility is the main cause for escalating the demand of Arts which is caused due to rapid change in lifestyle, smoking drinking, steroids, mental stress/trauma and other medical conditions like diabetes, cystic fibrosis, trauma, testicular failure, and fallopian tube blockage, ovarian dysfunction in females, etc. Therefore, these factors are supporting the growth and development of IVF market.

To track the trends of the IVF market globally, BIS Research study includes qualitative and quantitative analysis of the market. The qualitative models of the market include industry attractiveness analysis, and market dynamics, among others. Industry attractiveness analysis provides an in-depth analysis of the level of competitiveness IVF market players. The market dynamics section summarizes the overall trend analysis of the market. The market dynamics section describes the factors driving and restraining the market growth, including the opportunities in the IVF market. The report also provides a comprehensive study of the prominent regulations, consortiums, patents and standards of the global IVF market.

Studied IVF market in our report coverage includes markets byprocedure, instruments, reagents &media, and geographies. The above mentioned sections have been analyzed quantitatively and the market value is evaluated and discussed in their respective sections in this report.

The answers to the following key questions can be found in the report:
•    What are the major market drivers, challenges and opportunities of the IVF market and their use cases?
•    What are the key trends and developments in the IVF market for genetic disease management? 
•    What are the different types of instruments, reagents and media used in the IVF procedures?
•    How will the key market players leverage on key developments such as mergers and acquisitions, partnerships, and product launches among others?
•    Which geographical region will lead the global IVF market by the end of the forecast period?
•    Who are the key players in the global IVF market?
•    What are the recent key market trends and key developments in different geographical regions?
•    What are the different procedures present in IVF market?
•    What is the global and regional market for IVF through 2022?
•    What is the status of IVF in developed, developing and other countries?

The report includes the profiles of major players in the IVF market that allows the readers to gain an insight into the various industry trends.

TABLE OF CONTENT
Executive Summary
1 Research Scope and Methodology
1.1 Scope of the Report
1.2 The Global IVF Market Research Methodology
1.2.1 Primary Data Sources
1.2.2 Secondary Data Sources
2 Introduction to IVF Market
2.1 Evolution and IVF Technology Advancement
2.2 IVF Market by End Users
2.2.1 Hospitals
2.2.2 Surgical Centre
2.2.3 Clinical Research Institutes
2.2.4 Fertility Clinics
3 Market Dynamics
3.1 Market Drivers
3.1.1 Infertility Increasing at a High Rate
3.1.2 Increasing Awareness and Willingness about Egg and Sperm Donation
3.1.3 Presence of Surrogacy Market
3.1.4 Advancement of Assisted Reproductive Technologies and Methods
3.1.5 Others
3.2 Market Challenges
3.2.1 High Cost of the Whole Tenure of the IVF Procedure
3.2.2 Ethical Issues and Social Justice
3.2.3 Lack of Awareness and Education in Developing Countries
3.2.4 Increasing Cases of Multiple Births and Pregnancies
3.3 Market Opportunities
3.3.1 Availability of “Direct to Consumer Tests”
3.3.2 Focus toward Pre-Implantation Genetic Diagnosis
4 Competitive Insights
4.1 Key Market Developments & Strategies
4.1.1 New Product Launch, Development and Expansion
4.1.2 Acquisitions, Partnerships, Mergers and Collaborations
4.1.3 Business Contracts, Patents, Approvals & Other Events
4.2 Industry Attractiveness Analysis
5 Industry Analysis
5.1 Patent Analysis
5.2 Regulatory Bodies & Associations
5.3 Value Chain Analysis
6 Global IVF Market, Analysis & Forecast
6.1 Assumptions & Limitations for Analysis and Forecast of the Global IVF Market
6.2 Global IVF Market by Procedures
6.2.1 Intracytoplasmic Sperm Injection (ICSI)
6.2.2 Frozen Embryo Replacement (FER)
6.2.3 ZIFT and GIFT
6.2.3.1 Zygote Intrafallopian Transfer (ZIFT)
6.2.3.2 Gamete Intrafallopian Transfer (GIFT)
6.2.4 Others
6.3 Global IVF Market by Instruments and Reagents & Media
6.3.1 Instruments
6.3.1.1 Incubators
6.3.1.2 Cryosystem
6.3.1.3 Imaging System
6.3.1.4 Ovum Aspiration Pump
6.3.1.5 Sperm Separation System
6.3.1.6 Micro Manipulator System
6.3.1.7 Other Accessories and Disposables
6.3.1.7.1 Semen Analysis Chamber
6.3.1.7.2 Plastic Ware
6.3.1.7.3 Oocyte Retrieval Needles
6.3.1.7.4 Miscellaneous Disposables
6.3.2 Reagents and Media
6.3.2.1 Cryopreservation Media
6.3.2.2 Semen Processing Media
6.3.2.3 Embryo Culture Media
6.3.2.4 Others
6.4 IVF Market by Geography
6.4.1 North America
6.4.1.1 Market Analysis by Country
6.4.1.2 Recent Key Developments
6.4.1.3 Key players
6.4.2 Europe
6.4.2.1 Market Analysis by Country
6.4.2.2 Key Developments
6.4.2.3 Key Players
6.4.3 APAC
6.4.3.1 Market Analysis by Country
6.4.3.2 Key Developments
6.4.3.3 Key Players
6.4.4 Rest of the World (RoW)
6.4.4.1 Market Analysis by Country/Region
6.4.4.2 Key Developments
6.4.4.3 Key Players
7 Key Company Profiles
7.1 Affymetrix, Inc.
7.1.1 Overview
7.1.2 Financials
7.1.2.1 Financial Summary
7.1.3 SWOT Analysis
7.2 CombiMatrix
7.2.1 Overview
7.2.2 Financials
7.2.2.1 Financial Summary
7.2.3 SWOT Analysis
7.3 Illumina Inc.
7.3.1 Overview
7.3.2 Financials
7.3.2.1 Financial Summary
7.3.3 SWOT Analysis
7.4 LabCorp Of America
7.4.1 Overview
7.4.2 Financials
7.4.2.1 Financial Summary
7.4.3 SWOT Analysis
7.5 Quest Diagnostics
7.5.1 Overview
7.5.2 Financials
7.5.2.1 Financial Summary
7.5.3 SWOT Analysis
7.6 Roche Holding
7.6.1 Overview
7.6.2 Financials
7.6.2.1 Financial Summary
7.6.3 SWOT Analysis
7.7 Thermo Fisher Scientific
7.7.1 Overview
7.7.2 Financials
7.7.2.1 Financial Summary
7.7.3 SWOT Analysis
7.8 OvaScience
7.8.1 Overview
7.8.2 Financials
7.8.2.1 Financial Summary
7.8.3 SWOT Analysis
7.9 VitroLife
7.9.1 Overview
7.9.2 Financials
7.9.2.1 Financial Summary
7.9.3 SWOT Analysis
7.10 Snapshot of Other Key Players
7.10.1 Abbott Laboratories
7.10.2 Genea Biomedx
7.10.3 Irvine Scientific
7.10.4 Qiagen, Inc.
7.10.5 GE Healthcare
7.10.6 BioMérieux SA
7.10.7 Cepheid Inc.
7.10.8 List of Other Prominent Players
List of Tables
Table 1  Statistical Snapshot: Global IVF Market, by Procedure, 2015-2022
Table 2  Statistical Snapshot: Global IVF Market, by Geography, 2015-2022
Table 4.1  New Product Launch, Development and Expansion
Table 4.2  Recent Acquisitions, Partnerships, Mergers and Collaborations
Table 4.3  Recent Business Contracts, Patents, Approvals & Other Events
Table 4.4  Key Factors Considered for Threat of New Entrants
Table 4.5  Key Factors Affecting Bargaining Power of Buyers
Table 4.6  Key Factors Affecting the Bargaining Power of Suppliers
Table 4.7  Key Factors Affecting the Threat of Substitute
Table 4.8  Key Factors Determining Intensity of Competitive Rivalry
Table 5.1  Examples of Some Recent Patents
Table 5.2  Example of Some Regulatory Bodies/Associations/Consortium
Table 6.1  Recent Key Developments in North America
Table 6.2  Recent Key Developments in Europe
Table 6.3  Recent Key Developments in APAC
Table 6.4  Recent Key Developments in ROW
Table 6.9  List of Other Prominent Players
List of Figures
Figure 1  Pregnancy and Live Birth Rates, Through ART Cycles, by Women Age, 2012
Figure 2  Global IVF Market, by Procedure, 2015 and 2022 ($Billion)
Figure 3  Global IVF Market, by Type, 2015 and 2022 ($Billion)
Figure 4  Global IVF Market, by Geography, 2015 and 2022 ($Billion)
Figure 1.1  Global IVF Market Scope
Figure 1.2  Bottom-Up Approach for IVF Market Estimation
Figure 2.1  The IVF Process
Figure 2.2  IVF Market: Key Elements Covered
Figure 2.3  History & Evolution of IVF
Figure 3.1  IVF Market: Market Dynamics
Figure 3.2  IVF Market: Key Market Drivers
Figure 3.3  IVF: Key Challenges
Figure 3.4  IVF: Key Opportunities
Figure 4.1  Recent Market Development Strategy Snapshot Analysis
Figure 4.2 Key Market Developments & Strategies
Figure 4.3  Porter’s Five Forces Analysis
Figure5.1 Value Chain Analysis
Figure 6.1  Treatments Used in IVF
Figure 6.2  Global IVF Market Value, by Procedure, 2015-2022 ($Million)
Figure 6.3  ICSI Procedures Used in IVF
Figure 6.4  Instruments Used in ICSI
Figure 6.5  Reagents Used in ICSI
Figure 6.6  Advantages& Disadvantages of ICSI
Figure 6.7  Global IVF Market, by ICSI Procedure, 2015-2022 ($Million)
Figure 6.8  Procedure, Instruments and Media Used in FER
Figure 6.9  Global IVF Market, by FER Procedure, 2015-2022 ($Million)
Figure 6.10  Procedures of ZIFT and GIFT
Figure 6.11  Advantages and Disadvantages of ZIFT and GIFT Procedure
Figure 6.12  Global IVF Market, by ZIFT & GIFT Procedure, 2015-2022 ($Million)
Figure 6.13  Global IVF Market, by Other Procedures, 2015-2022 ($Million)
Figure 6.14  Global IVF Market, by Instruments, 2015-2022 ($Million)
Figure 6.15  Different IVF Incubators
Figure 6.16  Benefits of Time Lapse Incubator
Figure 6.17  Other Types of Incubator
Figure 6.18  Global IVF Market, by Incubator, 2015-2022 ($Million)
Figure 6.19  Cryosystem Types
Figure 6.20  Global IVF Market, by Cryosystem, 2015-2022 ($Million)
Figure 6.21  Global IVF Market, by Imaging System, 2015-2022 ($Million)
Figure 6.22  Global IVF Market, by Ovum Aspiration Pump, 2015-2022 ($Million)
Figure 6.23  Global IVF Market, by Sperm Separation System, 2015-2022 ($Million)
Figure 6.24  Global IVF Market, by Micro Manipulator System, 2015-2022 ($Million)
Figure 6.25  Global IVF Market, by Other Instruments, 2015-2022 ($Million)
Figure 6.26  Sperm Counting Chambers
Figure 6.27  Global IVF Market, by Semen Analysis Chamber, 2015-2022 ($Million)
Figure 6.28  Global IVF Market, by Plastic Ware, 2015-2022 ($Million)
Figure 6.29  Global IVF Market, by Oocyte Retrieval Needles, 2015-2022 ($Million)
Figure 6.30  Global IVF Market, by Miscellaneous Disposables, 2015-2022 ($Million)
Figure 6.31  Global IVF Market, by Cryopreservation Media, 2015-2022 ($Million)
Figure 6.32  Global IVF Market, by Semen Processing Media, 2015-2022 ($Million)
Figure 6.33  Global IVF Market, by Embryo Culture Media, 2015-2022 ($Million)
Figure 6.34  Global IVF Market, by Other Reagents, 2015-2022 ($Million)
Figure 6.35  Global IVF Market: Geography Coverage
Figure 6.36  Factors Affecting IVF Market in North America
Figure 6.37  Global IVF Market, by Geography, 2015-2022 ($Million)
Figure 6.38  North America: IVF Market Recent Trends
Figure 6.39  North America: IVF Market, 2015-2022 ($Million)
Figure 6.40  North America: IVF Market, by Countries, 2015-2022 ($Million)
Figure 6.41  Key Players in North American IVF Market
Figure 6.42  IVF Market Recent Trends in Europe
Figure 6.43  Europe: IVF Market, 2015-2022 ($Million)
Figure 6.44  Europe: IVF Market, by Countries, 2015-2022 ($Million)
Figure 6.45  Key Players in European IVF Market
Figure 6.46  IVF Market Recent Trends in APAC
Figure 6.47  APAC: IVF Market, 2015-2022 ($Million)
Figure 6.48  APAC: IVF Market, by Countries, 2015-2022 ($Million)
Figure 6.49  Key Players in APAC IVF Market
Figure 6.50  IVF Market Recent Trends in ROW
Figure 6.51  ROW: IVF Market, 2015-2022 ($Million)
Figure 6.52  ROW: IVF Market, by Regions, 2015-2022 ($Million)
Figure 6.53  Key Players in ROW IVF Market
Figure 7.1  Affymetrix: Overall Financials, 2013-2015
Figure 7.2  Affymetrix: Net Revenue by Business Segment, 2013-2015
Figure 7.3   Affymetrix: Revenue across Different Geographies, 2013-2015
Figure 7.4  Affymetrix: SWOT Analysis
Figure 7.5  CombiMatrix: Overall Financials, 2013-2015
Figure 7.6  CombiMatrix: SWOT Analysis
Figure 7.7  Illumina: Overall Financials, 2013-2015
Figure 7.8  Illumina: Net Revenue by Business Segment, 2013-2015
Figure 7.9  Illumina: Revenue across Different Geographies, 2013-2015
Figure 7.10  Illumina: SWOT Analysis
Figure 7.11  LabCorp: Overall Financials, 2013-2015
Figure 7.12  LabCorp: Net Revenue by Business Segment, 2013-2015
Figure 7.13  LABCORP: SWOT Analysis
Figure 7.14  Quest Diagnostics: Overall Financials, 2013-2015
Figure 7.15  Quest Diagnostics: Net Revenue by Business Segments, 2013-2015
Figure 7.16  Quest Diagnostics: SWOT Analysis
Figure 7.17  Roche Holding: Overall Financials, 2013-2015
Figure 7.18  Roche Holding: Net Revenue by Business Segments, 2013-2015
Figure 7.19  Roche Holding: Revenue across Different Geographies, 2013-2015
Figure 7.20  Roche Holding: SWOT Analysis
Figure 7.21  Thermo Fisher Scientific: Overall Financials, ($Billion)
Figure 7.22  Thermo Fisher Scientific: Net Revenue by Business Segments, ($Billion)
Figure 7.23  Thermo Fisher Scientific: Net Revenue by Geography, ($Billion)
Figure 7.24  Thermo Fisher Scientific: SWOT Analysis
Figure 7.25  OvaScience: Overall Financials, ($Million)
Figure 7.26  OvaScience: SWOT Analysis
Figure 7.27  VitroLife: Overall Financials, ($Million)
Figure 7.28  VitroLife: Net Revenue by Business Segments, ($Thousand)
Figure 7.29  VitroLife: Net Revenue by Geography, ($Thousand)
Figure 7.30  VitroLife: SWOT Analysis

High infertility rate and degrading reproductive health conditions have triggered the development of Assisted Reproductive Technology (ART) in the early 1990s. There are copious benefits of these techniques such as prevention of communicable diseases, genetic or hereditary disorders among others. Due to these reasons, couples who are unable to bear children, have been compelled to adopt one or more ART methods for conceiving a child. 

There are various types of ART techniques, among which the most frequently used techniques are In-Vitro fertilization (IVF), and Intra Uterine Insemination (IUI). The In-Vitro fertilization (IVF) technique, which is an amateur market, has the potential to be one of the biggest market boosters in the future. 

The IVF process is directly related to the birth of a child, which is directly intertwined with the patient’s emotional and physical health. In many developing countries, the IVF market’s growth is restrained due to their cultural and ethical attitude towards this process. However, the government has introduced educational programs and regulations, which are contributing in building a platform, for the development of the IVF market. 

The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. The global market is expected to grow over $26.08 billion by 2022. IVF Market can be further divided into various segments and sub-segments.

The IVF procedure market has been divided into four main categories viz. Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Zygote Intrafallopian transfer (ZIFT) and Gamete Intrafallopian Transfer (GIFT) among others. Globally ICSI is the most frequently used technology, and currently accounts for two-third of the world's IVF market. Market share of ICSI is expected to decline in the future due to increasing investments in Frozen Embryo Replacement (FER) which is preferred by various end users like armed forces personnel and High Net worth Individual (HNI) among others.

Due to their limited applications, ZIFT and GIFT procedures reserve a small market share. These procedures are used only in special cases where the first IVF cycle is unsuccessful or the mother is facing serious issues in conceiving. Both these procedures are invasive, and thus, are less preferred in developed countries.

European countries prefer IVF treatments and egg donations, especially Spain which has highest number of egg donors, followed by Poland and Ukraine. In countries like the U.S., the U.K., Spain, France, and Denmark, the donor number has doubled in a span of 10 to 15 years. Moreover, the availability of skilled personnel, high quality of treatments at economical prices, and increasing awareness of IVF treatments are some of the major factors that are contributing to the growth of the European IVF market. 

The increasing infertility cases, advancement of technologies, government support & regulations, educational awareness programs, and emerging reimbursement policies are some of the major factors driving the growth trajectory of this market. The development of pre-implantation diagnosis tests are helping parents to know about the well being of their baby in early stages of pregnancy and hence are foreseen as a viable opportunity for this market.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 
 
* Required Fields

OUR HAPPY CLIENTS


related reports

 

OUR CLIENTS